Inhibition of mTOR reduces anal carcinogenesis in transgenic mouse model
about
Immunocompromised and immunocompetent mouse models for head and neck squamous cell carcinomaInhibition of survivin reduces HIF-1α, TGF-β1 and TFE3 in salivary adenoid cystic carcinoma.Comprehensive multiplatform biomarker analysis of 199 anal squamous cell carcinomas.Mutational analysis of anal cancers demonstrates frequent PIK3CA mutations associated with poor outcome after salvage abdominoperineal resection.Biomarkers in anal cancer: from biological understanding to stratified treatment.Targeting phosphorylation of STAT3 delays tumor growth in HPV-negative anal squamous cell carcinoma mouse model.
P2860
Inhibition of mTOR reduces anal carcinogenesis in transgenic mouse model
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Inhibition of mTOR reduces anal carcinogenesis in transgenic mouse model
@en
Inhibition of mTOR reduces anal carcinogenesis in transgenic mouse model.
@nl
type
label
Inhibition of mTOR reduces anal carcinogenesis in transgenic mouse model
@en
Inhibition of mTOR reduces anal carcinogenesis in transgenic mouse model.
@nl
prefLabel
Inhibition of mTOR reduces anal carcinogenesis in transgenic mouse model
@en
Inhibition of mTOR reduces anal carcinogenesis in transgenic mouse model.
@nl
P2093
P2860
P1433
P1476
Inhibition of mTOR reduces anal carcinogenesis in transgenic mouse model
@en
P2093
Ashok B Kulkarni
Bradford Hall
Yansong Bian
Zhi-Jun Sun
P2860
P304
P356
10.1371/JOURNAL.PONE.0074888
P407
P577
2013-10-04T00:00:00Z